{
  "id": "clinical#screening_cues_76185fd7",
  "content": "specified substance, or use or discontinuation of a psychoactive medication.\n• The intensity or duration of the anxiety symptoms is substantially in excess of anxiety\nsymptoms that are characteristic of intoxication or withdrawal due to the specified\nsubstance.\n• The specified substance, as well as the amount and duration of its use, is known to be\ncapable of producing anxiety symptoms (see the list above and Table 6.14, p. 454).\n• The symptoms are not better accounted for by another mental disorder such as an anxiety\nor fear-related disorder, a depressive disorder with prominent anxiety symptoms, or post-\ntraumatic stress disorder. Evidence supporting a diagnosis of another mental disorder\nSubstance-induced anxiety disorders\n494 Clinical Descriptions and Diagnostic Requirements for ICD-11 Mental, Behavioural or Neurodevelopmental Disorders\nwould include anxiety symptoms preceding the onset of the substance use, the symptoms\npersisting for a substantial period of time after cessation of the substance or medication\nuse or withdrawal (e.g. 1 month or more depending on the specific substance), or other\nevidence of a pre-existing mental disorder with anxiety symptoms (e.g. a history of prior\nepisodes not associated with substance use).\n• The symptoms are not a manifestation of another medical condition.\n• The symptoms result in significant distress or significant impairment in personal, family,",
  "metadata": {
    "source": "WHO ICD-11",
    "url": "https://icd.who.int/",
    "condition": "General",
    "risk_band": "low",
    "topics": [
      "stress",
      "relationships",
      "screening_cues",
      "management",
      "psychoeducation"
    ],
    "is_clinical": true,
    "is_advice": false
  },
  "index_text": "General — Screening Cues specified substance, or use or discontinuation of a psychoactive medication.\n• The intensity or duration of the anxiety symptoms is substantially in excess of anxiety\nsymptoms that are characteristic of intoxication or withdrawal due to the specified\nsubstance.\n• The specified substance, as well as the amount and duration of its use, is known to be\ncapable of producing anxiety symptoms (see the list above and Table 6.14, p. 454).\n• The symptoms are not better accounted for by another mental disorder such as an anxiety\nor fear-related disorder, a depressive disorder with prominent anxiety symptoms, or post-\ntraumatic stress disorder. Evidence supporting a diagnosis of another mental disorder\nSubstance-induced anxiety disorders\n494 Clinical Descriptions and Diagnostic Requirements for ICD-11 Mental, Behavioural or Neurodevelopmental Disorders\nwould include anxiety symptoms preceding the onset of the substance use, the symptoms\npersisting for a substantial period of time after cessation of the substance or medication\nuse or withdrawal (e.g. 1 month or more depending on the specific substance), or other\nevidence of a pre-existing mental disorder with anxiety symptoms (e.g. a history of prior\nepisodes not associated with substance use).\n• The symptoms are not a manifestation of another medical condition.\n• The symptoms result in significant distress or significant impairment in personal, family, Specified substance, or use or discontinuation of a psychoactive medication. • the intensity or duration of the lo âu symptoms is substantially in excess of lo âu\nsymptoms that are characteristic of intoxication or withd..."
}